Skip to main content

Congleton Jon

Chief Executive Officer

1 company

Insider Signal Score

47
Average
Trades Analyzed
18
12M Win Rate
7.1%
Avg 3M Return
-3.3%
Avg 12M Return
-23.6%

Congleton Jon is a Chief Executive Officer at Mineralys Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 19 sells.

Estimated insider holdings value: $18.0M based on current market prices.

Holdings by Company

MLYSApr 13, 2026
Current Shares689.3K
Value$18.05M
Net Activity-438,979
Bought: 10.8KSold: 449.7K

Transaction History

Showing 10 filings
DateTickerRoleTypeSharesPriceValueChg%3M12MSEC
Apr 13, 2026
MLYS
Mineralys Therapeutics, Inc.
Chief Executive OfficerSell15,730$26.83$421,979.27-2.2%--
Jan 12, 2026
MLYS
Mineralys Therapeutics, Inc.
Chief Executive OfficerSell16,236$32.62$529,639.60-1.2%-19.3%-
Nov 11, 2025
MLYS
Mineralys Therapeutics, Inc.
Chief Executive OfficerSell200,000$45.44$9,088,498.87-4.3%-32.6%-
Oct 13, 2025
MLYS
Mineralys Therapeutics, Inc.
Chief Executive OfficerSell15,100$42.67$644,326.87-0.9%-23.4%-
Jul 11, 2025
MLYS
Mineralys Therapeutics, Inc.
Chief Executive OfficerSell15,884$14.51$230,430.78-1.8%+171.8%-
Apr 11, 2025
MLYS
Mineralys Therapeutics, Inc.
Chief Executive OfficerSell15,319$12.19$186,802.95-1.7%+9.3%+98.7%
Jan 13, 2025
MLYS
Mineralys Therapeutics, Inc.
Chief Executive OfficerSell18,333$9.06$166,082.31-2.0%+48.7%+251.9%
Oct 11, 2024
MLYS
Mineralys Therapeutics, Inc.
Chief Executive OfficerSell15,271$13.52$206,433.38-1.7%-27.2%+210.9%
Jul 11, 2024
MLYS
Mineralys Therapeutics, Inc.
Chief Executive OfficerSell15,746$13.34$210,075.26-1.7%+1.0%+6.8%
Jun 20, 2024
MLYS
Mineralys Therapeutics, Inc.
Chief Executive OfficerSell49,313$12.01$592,022.00-1.7%-0.2%+15.1%
Page 1Next →